Infection of Human Papillomavirus (HPV) and Epstein-Barr Virus (EBV) and p53 expression in human esophageal carcinoma

Journal of the Pakistan Medical Association

Volumn 48, Issue 5, 1998, Pages 138-142

  Khurshid, Anwar ^a,b   Kazuya, Nakakuki ^a   Hanae, Imai ^a   Manabu, Inuzuka ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b Aqaf Plaza ^*  (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGE; AGED; ARTICLE; CANCER INVASION; CARCINOMA; COCARCINOGENESIS; COMPARATIVE STUDY; DNA SEQUENCE; EPSTEIN BARR VIRUS; ESOPHAGUS; ESOPHAGUS TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; MIDDLE AGED; MUTATION; PAPILLOMA VIRUS; PATHOLOGY; POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TUMOR SUPPRESSOR GENE; VIROLOGY; VIRUS INFECTION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA; COCARCINOGENESIS; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEX FACTORS; TUMOR VIRUS INFECTIONS;

EID: 0032064617     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Chang, F., Syrjanen, S., Wang, L. et al. Infectious agents in the etiology of esophageal cancer. Gastroentrology, 1992;103:1336-1348.
2. Robey-Cafferty, S.S., El-Naggar, A.K., Sahin, A.A. et al. Prognostic factors in esophageal squamous cell carcinoma. A study of histologic features, blood group expression and DNA ploidy. Am. J. Clin. Pathol., 1991;95:844-849.
3. Syrjanen, K., Gissman, L. and Koss, L.G. (eds). Papillomaviruses and human disease. Berlin, Springer, 1987.
4. Chang, F., Syrjanen, S., Kurvinen, K. et al. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis. Am. J. Gastroenterol., 1993;88:174-186.
5. Scheffner, M., Wemess, B.A., Huibregtse, J.M. et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. cell, 1990;63:1129-1136.
6. Crook, T., Wredo, D. and Vousden, K.V. p53 mutations in HPV-negative human cervical carcinoma cell lines. Oncogene, 1991;6:873-875.
7. Crook, T., Wrede, D., Tidy, J.A. et al. Clonal p53 mutations in primary cervical cancer. Association with human papillomavirus negative tumors. Lancet, 1992;339:1070-1073.
8. Anwar, K., Nakakuki, K. and Imai, H. Over-expression of p53 protein inhuman laryngeal carcinoma. Int. J. Cancer, 1993;53:423-426.
9. Anwar, K., Nakakuki, K., Imai, H. et al. Infection of human papillomavirus (HPV) and Epstein-Barr virus (EBV) and p53 overexpression in human gastric carcinoma. Int.J. Oncol., 1996;7:391-397.
10. Japanese Society for esophageal diseases. Guide lines for the clinical and pathologic studies on carcinoma of the esophagus. 7th ed., Tokyo, Kanehara, 1989.
11. Anwar, K., Naiki, H., Nakakuki, K. et al. High frequency of human papillomavirus infection in carcinoma of urinary bladder. Cancer, 1992;70:1967-1973.
12. Anwar, K., Nakakuki, K., Imai, H. et al. High frequency of human papillomavirus (HPV) and p53 overexperession in human female genital tract carcinoma. JPMA; 1996;46:220-224.
13. Maniatis, T., Fritsch, E.F. and Sambrook, J. Molecular Cloning: A laboratory manual. Cold Spring Harbor, New York., Cold Spring Harbor Laboratory, 1989, pp. 9, 16-19.
14. Midgley, C.A., Fisher, C.J., Bartek, J. et al. Analysis of p53 expression in human tumors: An antibody raised against human p53 expressed in Escherichia coli. J. Cell. Sci., 1992;101:183-189.
15. Syrjanen, K.J. Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Arch. Geschwulstforsch, 1982;52:283-292.
16. Toh, Y., Kuwano, H., Tanaka, S. et al. Detection of human papillomavirus DNA in esophageal carcinoma in Japan by polymerase reaction. Cancer, 1992;70:2234-2238.
17. Furihata, M., Ohtsuki, Y., Ogoshi, S. et al. Prognostic significance of human papillomavirus genomes (type-16, 18) and aberrant expression of p53 protein in human esophageal cancer. Int. J. Cancer, 1993;54:226-230.
18. Benamouzig, R., Pigot, F., Quiroga, G. et al. Human papillomavirus infection in esophageal squamous cell carcinoma in Western countries. Int. J. Cancer, 1992;50:549-552.
19. Shibata, D. and Weiss, L.M. Epstein Barr virus associated gastric adenocarcinoma. Am. J. Pathol., 1992;140:769-774.
20. Purtilo, D.T., Strobach, S., Okano, M. et al. Biology of disease: Epstein-Barr virus associated lymphoproliferative disorders. Lab.Invest. 1992;67:5-23.
21. Maestro, R., Dolcetti, R. and Gasparotto, D. High frequency of p53 gene alteration associated with protein over-expression in human squamous cell carcinoma of the larynx. Oncogene, 1992;7:1159-1166.
22. Lam, K.Y., Chan, A.C., Chan, K.W. et al. Expression of p53 and its relationship with human papillomavirus in penile carcinomas. Eur. J. Surg. Oncol., 1995;21:613-616.
23. Li, X. and Coffino, P. High risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation. J. Virol., 1996;70:4509-4516.
24. Suzuki, T., Tsutsumi, K. and Nakajima, T. Spontaneous mutation of p53 gene in human papillomavirus type 16 E7-immortalized human laryngeal epithelial cells. Acta Otolaryngol., 1996;522:94-98.